Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults

Clinical trial NCT04983030 · COMPLETED

Trial details

NCT number: NCT04983030
Sponsor: Boris Juelg, MD PhD
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV Acquired Immunodeficiency Syndrome Immunologic Deficiency Syndrome, Acquired Sexually Transmitted Diseases, Viral Retroviridae Infections

Start date: 2022-04-01
Primary completion: 2026-02-23
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.